Obligations of Marketplace E-commerce entities and Inventory E-commerce entities.

This post examines the legal obligations and liabilities for marketplace and inventory e-commerce entities under Indian law. It highlights the key compliance requirements and distinguishes between the two models as per the proposed amendments to the Consumer Protection E-Commerce Rules.

Read more about Obligations of Marketplace E-commerce entities and Inventory E-commerce entities.

CASE BRIEF : Sun Pharmaceutical Industries Limited vs Cipla Limited

The Madras High Court addressed trademark and copyright infringement claims in Sun Pharmaceutical vs Cipla, focusing on drug packaging similarities. The interim injunction granted to Cipla was upheld, balancing public interest against intellectual property rights.

Read more about CASE BRIEF : Sun Pharmaceutical Industries Limited vs Cipla Limited

Overall decrease in patent statistics, pandemic continues to stifle numbers

Recent Indian patent statistics indicate a decrease in published applications and a rise in granted patents, reflecting ongoing effects of the pandemic. The report also notes an increase in industrial design registrations, illustrating shifting trends in intellectual property filings.

Read more about Overall decrease in patent statistics, pandemic continues to stifle numbers

Miley Cyrus Wins at CJEU, Adidas and LEGO Join Hands, and more

This bulletin highlights significant updates in trademark law, including international and Indian cases, brand collaborations, and geographical indication news. The analysis is compiled by BananaIP Counsel, offering a factual and structured overview for readers interested in intellectual property.

Read more about Miley Cyrus Wins at CJEU, Adidas and LEGO Join Hands, and more

After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more

Bajaj Healthcare has applied for a compulsory license against Eli Lilly for Baricitinib, citing affordability concerns. The post also covers the EPO’s decision on double patenting, updates from the IP5 meeting on AI patents, and new initiatives by WHO, WTO, and WIPO.

Read more about After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more